Viewing Study NCT01598051


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-01-05 @ 6:06 PM
Study NCT ID: NCT01598051
Status: COMPLETED
Last Update Posted: 2019-05-30
First Post: 2012-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-valvular Atrial Fibrillation (NVAF) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Xarelto View
None SPAF View
None QOL View